VIVUS to Present at Biotech Showcase on January 13, 2020
January 02 2020 - 6:30AM
VIVUS, Inc. (Nasdaq: VVUS) (the “Company”), a biopharmaceutical
company, today announced that John Amos, Chief Executive Officer,
will present at the Biotech Showcase™ 2020 on Monday, January 13,
2020 at 3:30 pm PT/6:30pm ET. The conference will be held at the
Hilton San Francisco Union Square.
An audio webcast of the presentation will be
available in the events and presentations section of the Company’s
investor relations website, or by clicking here.
Biotech Showcase, produced by Demy-Colton and
EBD Group, is an investor conference focused on driving advances in
therapeutic development by providing a sophisticated networking
platform for executives and investors that fosters investment and
partnership opportunities. The conference takes place each year
during the course of one of the industry's largest gatherings and
busiest weeks.
About VIVUS
VIVUS is a biopharmaceutical company
committed to the development and commercialization of innovative
therapies that focus on advancing treatments for patients with
serious unmet medical needs. For more information about the
Company, please visit www.vivus.com.
Forward-Looking Statements
Certain statements in this press release are
forward-looking within the meaning of the Private Securities
Litigation Reform Act of 1995. These statements may be identified
by the use of forward-looking words such as “anticipate,”
“believe,” “forecast,” “estimate,” “expect,” “intend,” “likely,”
“may,” “plan,” “potential,” “predict,” “opportunity” and “should,”
among others. There are a number of factors that could cause actual
events to differ materially from those indicated by such
forward-looking statements. VIVUS does not undertake an
obligation to update or revise any forward-looking statements.
Investors should read the risk factors set forth in VIVUS’ Form
10-K for the year ended December 31, 2018 as filed
on February 26, 2019, and periodic reports filed with
the Securities and Exchange Commission. VIVUS does
not undertake an obligation to update or revise any forward-looking
statements.
Contact:
VIVUS,
Inc. |
Lazar
FINN Partners |
Mark Oki |
David Carey |
Chief Financial Officer |
Senior Partner |
oki@vivus.com |
david.carey@finnpartners.com |
650-934-5200 |
212-687-1768 |
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From Apr 2024 to May 2024
VIVUS (NASDAQ:VVUS)
Historical Stock Chart
From May 2023 to May 2024
Real-Time news about VIVUS Inc (NASDAQ): 0 recent articles
More News Articles